Phenotype of patients with Charcot-Marie-Tooth with the p.His123Arg mutation in GDAP1 in northern Finland

• Main Authors: Lehtilahti, M. (Maria), Kallio, M. (Mika), Majamaa, K. (Kari), Kärppä, M. (Mikko)
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wolters Kluwer 2021
• Subjects: Charcot; Northern Finland
• Online Access: http://urn.fi/urn:nbn:fi-fe2022021418905

Abstract Background and Objectives: Mutations in the ganglioside-induced differentiation-associated protein 1 (GDAP1) gene cause autosomal dominant or autosomal recessive forms of Charcot-Marie-Tooth disease (CMT). Our aim was to study the clinical phenotype of patients with CMT caused by heterozygous p.His123Arg in GDAP1. Methods: Twenty-three Finnish patients were recruited from a population-based cohort and through family investigation. Each patient was examined clinically and electrophysiologically. The Neuropathy Symptom Score and the Neuropathy Disability Score (NDS) were used in clinical evaluation. Results: The median age at onset of symptoms was 17 years among patients with p.His123Arg in GDAP1. Motor symptoms were markedly more common than sensory symptoms at onset. All patients had distal weakness in lower extremities, and 17 (74%) patients had proximal weakness. Muscle atrophy and pes cavus were also common. Nineteen (82%) patients had sensory symptoms such as numbness or pain. The disease progressed with age, and the NDS increased 8.5 points per decade. Electrodiagnostic testing revealed length-dependent, sensory and motor axonal polyneuropathy. EDx findings were asymmetrical in 14 patients. Genealogic study of the families suggested a founder effect. Discussion: We found that CMT in patients with p.His123Arg in GDAP1 is relatively mild and slow in progression.